Binance CEO CZ Calls SBF a ‘Psychopath,’ 3AC Co-Founder Accuses FTX, Alameda of Stop Hunting His Hedge Fund (Bitcoin.com)
During a conversation with Binance CEO Changpeng Zhao (CZ) and the Milken Institute, the exchange executive called the former FTX CEO Sam Bankman-Fried (SBF) a “psychopath” for one of the tweets SBF wrote last week. CZ’s statements further follow the accusations stemming from Three Arrows Capital (3AC) co-founder Kyle Davies. The 3AC co-founder claimed that both FTX and Alameda Research “colluded to trade against clients.”
OQAM Chooses New Roadmap (Hedge Nordic)
Stockholm (HedgeNordic) – Despite delivering on its promise of preserving capital in this year’s market environment, Malmö-based OQAM has closed down its multi-strategy systematic hedge fund ia. Instead, OQAM will open up its innovation engine by offering individual strategies to other financial institutions and professional investors either through discretionary mandates or fund structures.
SS&C GlobeOp Hedge Fund Performance Index and Capital Movement Index (PRNewswire)
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced the gross return of the SS&C GlobeOp Hedge Fund Performance Index for October 2022 measured -0.96%. Hedge fund flows as measured by the SS&C GlobeOp Capital Movement Index advanced 0.13% in November. “SS&C GlobeOp’s Capital Movement Index was up 0.13% for November 2022, showing stabilization after outflows in October. However, the 12-month average has been up 0.07%, demonstrating the broad stagnation of flows which characterizes 2022,” said Bill Stone, Chairman and Chief Executive Officer, SS&C Technologies. “In the face of historical weakness across asset classes, hedge funds have generally been a steady port in the financial storm created by inflation and higher interest rates. The last two months of the year are historically strong seasonally, and this month’s stabilization could be a positive sign for short-term flows.”
Thursday 11/17 Insider Buying Report: ALIT, BHG (Nasdaq.com)
At Alight (ALIT), a filing with the SEC revealed that on Monday, Director Richard N. Massey bought 100,000 shares of ALIT, at a cost of $8.40 each, for a total investment of $840,500. Massey was up about 4.3% on the purchase at the high point of today’s trading session, with ALIT trading as high as $8.77 in trading on Thursday. Alight is trading up about 1.9% on the day Thursday. Before this latest buy, Massey bought ALIT at 3 other times during the past twelve months, for a total cost of $865,078 at an average of $9.61 per share. And also on Monday, Director Manuel Kadre purchased $291,175 worth of Bright Health Group (BHG), purchasing 303,307 shares at a cost of $0.96 each. Before this latest buy, Kadre bought BHG at 3 other times during the past year, for a total investment of $1.60M at an average of $2.30 per share. Bright Health Group is trading off about 0.2% on the day Thursday.
JPMorgan Chase, Bristol-Myers Squibb And 3 Other Stocks Insiders Are Selling (Benzinga)
Bristol-Myers Squibb: The Trade: Bristol-Myers Squibb Company (BMY) EVP, Chief Human Resources Ann Powell sold a total of 16,250 shares at an average price of $80.45. The insider received around $1.31 million from selling those shares. Crocs: The Trade: Crocs, Inc. (CROX) President Michelle Poole sold a total of 10,507 shares at an average price of $ $89.04. The insider received around $935.55 thousand as a result of the transaction.
